Brandon Hardesty, MD

What is the most exciting area of research you’re involved in?

At IHTC, we have a large enough patient base to study even ultra-rare blood disorders. For example, we recently published a study on a revolutionary new treatment we developed for Plasminogen Deficiency. Our findings are helping patients around the country and the world get better treatment for this rare disorder.

How does your research impact the way you treat your patients?

Studying complications and effective treatments for blood disorders keeps me focused on prevention with the patients I see day-to-day. I see the importance of proactive treatments and monitoring, helping patients reduce their risk factors, and avoiding those acute crises. Through my research, I’m connected with specialists worldwide, so when I do have a complicated situation with one of my patients, I’m able to reach out to an extensive team of experts to get the best possible recommendations.

What do you enjoy most about working at IHTC?

The multidisciplinary team approach here opens doors for better treatment that I didn’t even know existed before I started working at IHTC. Working with a team of experts in a variety of fields helps us to deliver care that really improves each patient’s wellbeing. For example, our pain management team considers at-risk patients individually to reduce their pain levels and help them feel better without over-reliance on opiates. And our joint ultrasound project makes it possible to treat adult hemophilia patients with targeted, data-driven treatments to prevent ongoing joint damage and reduce the risks for severe bleeding.